C07F 9/6515
Having three nitrogen atoms as the only ring hetero atoms
Official title: having three nitrogen atoms as the only ring hetero atoms
C07F9/6515 (Having three nitrogen atoms as the only ring hetero atoms) appears on 352 US grants and 246 published applications in this corpus.
Search patents in C07F- Granted patents
- 352
- Published applications
- 246
- Assignees
- 206
- Inventors
- 904
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 9 | 0 |
| 1978 | 6 | 0 |
| 1979 | 6 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 7 | 0 |
| 1983 | 2 | 0 |
| 1984 | 10 | 0 |
| 1985 | 9 | 0 |
| 1986 | 5 | 0 |
| 1987 | 6 | 0 |
| 1988 | 6 | 0 |
| 1989 | 3 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 1 | 0 |
| 1993 | 8 | 0 |
| 1994 | 11 | 0 |
| 1995 | 11 | 0 |
| 1996 | 7 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 12 | 6 |
| 2002 | 17 | 14 |
| 2003 | 11 | 4 |
| 2004 | 2 | 8 |
| 2005 | 2 | 6 |
| 2006 | 2 | 9 |
| 2007 | 9 | 10 |
| 2008 | 11 | 7 |
| 2009 | 1 | 5 |
| 2010 | 4 | 4 |
| 2011 | 2 | 3 |
| 2012 | 9 | 12 |
| 2013 | 6 | 9 |
| 2014 | 3 | 13 |
| 2015 | 8 | 15 |
| 2016 | 12 | 11 |
| 2017 | 9 | 14 |
| 2018 | 12 | 12 |
| 2019 | 8 | 13 |
| 2020 | 9 | 12 |
| 2021 | 8 | 12 |
| 2022 | 7 | 16 |
| 2023 | 8 | 4 |
| 2024 | 7 | 12 |
| 2025 | 7 | 10 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Bicyclic fused ring derivative or salt thereof and pharmaceutical composition comprising same21 Jul 2026US 12,686,665 B2Yuhan Corporation
- Long-lived gadolinium based tumor targeted imaging and therapy agents3 Mar 2026US 12,564,635 B2Wisconsin Alumni Research Foundation
- Application of click chemistry for signal amplification in IHC and ISH assays6 Jan 2026US 12,517,132 B2Ventana Medical Systems, Inc.
- Synthesis of phosphazene-covalent organic framework (COF) for enhanced lead capture with visual feedback23 Dec 2025US 12,502,652 B2United Arab Emirates University
- Gene delivery agents9 Dec 2025US 12,491,262 B2TIBA Biotech LLC
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Organic light emitting diode, display device comprising the same and compound6 Aug 2026US 2026/0231672 A1Novaled GmbH
- Novel compound as functional antagonist for s1pr1 and s1pr430 Apr 2026US 2026/0116902 A1Nextgen Bioscience Co., Ltd.
- Gene delivery agents12 Mar 2026US 2026/0069540 A1TIBA Biotech LLC
- Small molecule compounds with phosphorylated aryl structures and use thereof26 Feb 2026US 2026/0055126 A1Hangzhou PhecdaMed Co., Ltd.
Most cited
By later US patents
- Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon493US 4,476,301 ACentre National De La Recherche Scientifique · 1984
- Substituted alkanediphosphonic acids and pharmaceutical use159US 4,939,130 ACiba-Geigy Corporation · 1990
- Antiretroviral enantiomeric nucleotide analogs124US 6,057,305 AInstitute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic · 2000
- Antiretroviral enantiomeric nucleotide analogs113US 6,653,296 B1Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic · 2003
- Gadolinium chelates as NMR contrast agents112US 4,639,365 ABoard of Regents, The University of Texas System · 1987